Connor, Clark & Lunn Investment Management (CC&L)
RPRX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Royalty Pharma RPRX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$626K Buy
2022
Q4 		– Sell
2022
Q3 		$1.6M Buy
2022
Q2 		$662K Buy